Golden Biotechnology Revenue

Golden Biotechnology had revenue of 22.95M TWD in the half year ending June 30, 2024, a decrease of -62.33%. This brings the company's revenue in the last twelve months to 57.49M, down -69.05% year-over-year. In the year 2023, Golden Biotechnology had annual revenue of 63.43M, down -70.88%.

Revenue (ttm)

57.49M

Revenue Growth

-69.05%

P/S Ratio

40.94

Revenue / Employee

471.25K

Employees

122

Market Cap

2.68B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	63.43M	-154.40M	-70.88%
Dec 31, 2022	217.83M	136.06M	166.39%
Dec 31, 2021	81.77M	-7.06M	-7.94%
Dec 31, 2020	88.83M	5.53M	6.64%
Dec 31, 2019	83.29M	-7.99M	-8.75%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	8.32B
Caliway Biopharmaceuticals	49.98M
Bora Pharmaceuticals Co., LTD.	16.71B
Lotus Pharmaceutical	17.59B
Lumosa Therapeutics	37.82M
Oneness Biotech	112.20M
Polaris Group	75.65M
Center Laboratories	1.57B

Revenue Rankings